Clinical Trial Update: Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Cediranib (AZD2171) for advanced solid tumors, also examining hypertension management; the study is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: AstraZeneca | Conditions: Tumors | Phase 2 | Status: COMPLETED | Results posted: 2012-08-29